Top Markets
#1 Akedo Akedo +71.59%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.61%
#4 Cross Cross +43.52%
#5 Black Phoenix Black Phoenix +33.78%
#6 Cap Cap +25.61%
#7 Velvet Velvet +25.32%
#8 Ravencoin Ravencoin +17.91%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.35%
#10 DoubleZero DoubleZero +12.07%
Coin of the day
Akedo Akedo
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Clasificación en acciones #39101
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Precio por acción
$0.02243487
Última sincronización: 2025-06-04
Capitalización bursátil
$650.09K
Cambio (1 día)
0.39%
Cambio (1 año)
0.00%
País
SE
Comercio Lipidor AB (publ) (LIPI)

Categoría

Healthcare
Número de acciones en circulación de Lipidor AB (publ) (LIPI)
Número de acciones en circulación al December 2024: 251.84M
Según los últimos informes financieros y el precio de las acciones de Lipidor AB (publ), el número actual de acciones en circulación es 251.84M. Al final de December 2023, la empresa tenía 28.98M acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de Lipidor AB (publ) (LIPI) desde 2016 hasta 2026
Acciones en circulación al final de cada año
Año Acciones en circulación Cambiar
2026 (TTM) 251.84M -41.77%
2024 432.53M 1,392.66%
2023 28.98M 0.00%
2022 28.98M 1.83%
2021 28.45M 15.77%
2020 24.58M 21.63%
2019 20.21M 11.87%
2018 18.06M 0.00%
2017 18.06M 0.00%
2016 18.06M 0.00%
Acciones en circulación de empresas similares o competidores
Empresa Acciones en circulación Diferencia País
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 892.40M 254.35%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 2.44B 868.92%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.77B 603.22%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 796.00M 216.07%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 0.00 -100.00%
US